Health and Healthcare

Eli Lilly's Picking On Schizophrenics (LLY)

Picking on people with schizophrenia would seem to be very unfair. If it is a large corporation, the odds against prople with serious mental illness would really seem to be stacked against them.

Lawyers for patients who suffer from the awful disease have uncovered documents that show the Lilly played down the health risks of Zyprexa, the companies best selling drug for treating schizophrenia.The drug can cause weight gain and increase in blood sugar, both of which can cause diabetes.

The drug brings in $4.2 billion a year, so it is not hard to see why Lilly would try to dupe the mentally ill and their doctors.

According to the NY Times internal Lilly documents are "replete with references to Zyprexa’s importance to Lilly’s future and the need to keep concerns about diabetes and obesity from hurting sales"

At least the attorneys for these seriously ill people have a smoking gun.

And, at least Lilly is probably facing a major legal and PR disaster. Not good for the stock.

Douglas A. McIntyre can be reached at [email protected]. He does not own securities in companies that he writes about.

Essential Tips for Investing: Sponsored

A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.

Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.